A trial investigator concerned with a Part II examine run by the biotech 5 Prime Therapeutics has pled responsible to an insider buying and selling probe.
Daniel Catenacci entered a responsible plea on Monday for a single depend of securities fraud, Assistant US Legal professional Brian Havey tells Endpoints Information. Catenacci faces a most punishment of 25 years in jail, a advantageous or each. The sentencing date has not been set.
That is the newest, and sure ultimate, growth in a case that began in again in late 2020. In November that 12 months, Catenacci — a former College of Chicago affiliate professor and director of the gastrointestinal oncology program on the College of Chicago College of Medication — purchased greater than 8,700 shares of the biotech only a few hours earlier than the corporate launched constructive Part II trial outcomes.
Hold studying Endpoints with a free subscription
Unlock this story immediately and be part of 139,100+ biopharma execs studying Endpoints day by day — and it is free.
